VATIS UPDATE Article

The National Cancer Centre Singapore (NCCS), Chinese University of Hong Kong (CUHK) and Seoul National University Hospital (SNUH), Republic of Korea, have jointly launched the Asian Thoracic Oncology Research Group (ATORG), a central coordination platform for multi-centre clinical trials and translational research for thoracic malignancies in Asia. ATORG’s will be based in Singapore to design cutting-edge clinical studies that leverage each institution’s capabilities, and conduct proof-of-concept trials relevant to the treatment of thoracic cancers.

The agenda and clinical studies will be guided by a Scientific Committee comprising of representation from NCCS, CUHK, SNUH, National Taiwan University (NTU), National University Hospital (NUH), Singapore, University of Sydney, Australia, and Mahidol University, Bangkok. “Many practice-changing studies in EGFR mutation positive NSCLC have been led out of Asia and China, given the benefit of high prevalence in this region,” said Tony Mok, at CUHK.